EUVIMEDEUVIMED entdecken
Crossref

L26/P-005 Cumulative live birth outcomes following ICSI with testicular sperm: comparison between azoospermia and raised sperm DNA fragmentation

J.V. Sharma, K.C. Mantravadi, D.R. Gedela, S. Debnath

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von J.V. Sharma und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does the indication for testicular sperm aspiration—azoospermia versus raised sperm DNA fragmentation—affect cumulative live birth outcomes following ICSI? Summary answer Cumulative live birth rates were higher when TESA was performed for azoospermia compared with raised sperm DNA fragmentation. What is known already Testicular sperm aspiration (TESA) with intracytoplasmic sperm injection (ICSI) is the established treatment for azoospermia. More recently, TESA has been extended to non-azoospermic men with raised sperm DNA fragmentation (DFI), based on the hypothesis that testicular sperm may harbour lower DNA damage. However, available evidence is inconsistent and largely limited to per-transfer outcomes. Per-embryo transfer analyses fail to capture the true effectiveness of an ART intervention from a patient perspective. Cumulative live birth rate (CLBR) per initiated cycle is therefore considered a more clinically meaningful measure of treatment success Study design, size, duration This retrospective cohort study analysed ICSI cycles performed between 2014 and 2024 at a single tertiary fertility centre. A total of 579 initiated cycles were included: 324 cycles using TESA for raised DFI and 255 cycles using TESA for azoospermia. Cumulative outcomes were evaluated across up to three consecutive frozen embryo transfer (FET) cycles per initiated treatment. Participants/materials, setting, methods Only self-gamete ICSI cycles with female age ≤37 years and no preimplantation genetic testing were included. Men with raised DNA fragmentation (DFI ≥30% by SCSA) and azoospermic men with successful sperm retrieval underwent TESA. All embryos were cultured to blastocyst stage and cryopreserved. Each FET transferred two good-quality blastocysts. Primary outcomes were cycle cancellation, implantation, and miscarriage rates; secondary outcomes included blastocyst formation, multiple pregnancy, and live birth rates. Main results and the role of chance Fertilization rates were comparable between the raised DFI and azoospermia groups (86.7% vs 86.5%). Blastocyst formation was lower in the raised DFI group (42.4%) than in the azoospermia group (54.7%). Cycle cancellation due to absence of blastocyst formation occurred more frequently in azoospermia cycles (24.3% vs 6.2%). After the first FET, live birth rates were 38.7% in the raised DFI group and 62.0% in the azoospermia group. Subsequent FETs contributed additional live births in both cohorts; however, the cumulative live birth rate per initiated cycle remained lower in the raised DFI group (33.0%) compared with azoospermia (49.8%). Group comparisons were performed using chi-square or Fisher’s exact test for categorical variables and Student’s t-test or Mann–Whitney U test for continuous variables, as appropriate. Analyses were conducted per initiated cycle to account for repeated embryo transfers originating from the same stimulation cycle. Given the retrospective design, findings should be interpreted as exploratory. Limitations, reasons for caution The retrospective design, lack of randomisation, and absence of post-thaw sperm DNA assessment limit causal inference. Residual confounding and embryo-level clustering cannot be fully excluded. Wider implications of the findings Stratifying cumulative outcomes by indication for TESA provides clinically relevant prognostic information. These findings may assist ART practitioners in counselling couples and in weighing surgical sperm retrieval against less invasive sperm-selection strategies in men with raised DFI. Trial registration number No

Zitieren

APA

Sharma, J., Mantravadi, K., Gedela, D., & Debnath, S. (2026). L26/P-005 Cumulative live birth outcomes following ICSI with testicular sperm: comparison between azoospermia and raised sperm DNA fragmentation. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.341

Vancouver

Sharma J, Mantravadi K, Gedela D, Debnath S. L26/P-005 Cumulative live birth outcomes following ICSI with testicular sperm: comparison between azoospermia and raised sperm DNA fragmentation. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.341

BibTeX
@article{Sharma2026,
  author = {Sharma, J.V. and Mantravadi, K.C. and Gedela, D.R. and Debnath, S.},
  title = {L26/P-005 Cumulative live birth outcomes following ICSI with testicular sperm: comparison between azoospermia and raised sperm DNA fragmentation},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.341}
}
Kostenlos starten →